Inflammation” is an old topic in the medical world, and it was once very scary and hideous, and it has taken many people’s precious lives, but with the further development of modern medicine, the original face of “inflammation” is clearly understood, and with the rapid progress of antibiotics and immunomodulatory drugs, the real inflammation is gradually fading out of the “killer” list, and gradually becoming a “sheep”. The real inflammation has gradually faded out of the “killer” list and has gradually become a “sheep”. Today we are going to talk about the “bad wolves” in the “sheep’s clothing” of inflammation. Inflammatory breast cancer is a kind of breast cancer with special clinical signs, there is no inflammatory cell infiltration, don’t look at the name, in fact it is not inflammation, in fact it is an aggressive breast cancer with very poor prognosis. In fact, it is a kind of aggressive breast cancer with very poor prognosis. The clinical manifestations are progressive breast enlargement, diffuse redness, swelling, heat, pain or no pain, and the “orange peel sign”, which feels very much like acute inflammation, hence the name “inflammatory breast cancer”. Inflammatory breast cancer is not significantly related to young age and pregnancy, what does it mean? It means that inflammatory breast cancer often develops during non-pregnancy and lactation period, and acute inflammation is available during pregnancy and lactation period. If acute inflammatory clinical manifestations such as redness, swelling, heat and pain or no pain are found in breasts within a short period of time during non-pregnancy and lactation period, we must pay high attention to them and diagnose them carefully, and it is better not to seek medical treatment indiscriminately and think that we are taking anti-inflammatory drugs indiscriminately. We have seen several cases of inflammatory breast cancer being delayed by misdiagnosis and mistreatment, which is indeed horrible. It can be described as “helpless”. In principle, the treatment of inflammatory breast cancer is different from other breast cancers. After the diagnosis, we must first use comprehensive treatment, such as chemotherapy, endocrine, molecular targeting and other systemic treatments to control the disease, of course, under the premise of comprehensive pathological diagnosis. After the bombardment of comprehensive treatment, if clinical remission and/or pathological remission occurs, what does that mean? It is the obvious relief of redness, swelling, heat and pain or painless symptoms, local lymphedema significantly reduced (“orange peel sign” improved), or after the pathological results returned pathological remission after re-pathological sampling. Only then can local treatment modalities such as surgery or radiotherapy be implemented, and surgery absolutely cannot preserve the breast. If after continuous systemic treatment, clinical and pathological evaluation does not see remission, it is necessary to promptly change the comprehensive treatment plan until a comprehensive treatment plan that can provide clinical or pathological remission is found, and if surgery is rushed, it is bound to be impossible to end. The color of the subheading has changed, which means that it is not so “scary”, meaning that it will not affect survival, but will mostly cause disfigurement of the breast. This problem is also considered a form of inflammation, pathologically common chronic inflammatory cell infiltration, chronic granuloma formation, but the early stages of the disease is not accompanied by bacterial infection, in fact, to put it bluntly is a large class of autoimmune diseases, this stage with anti-inflammatory drugs are not effective. After the development of a certain stage may be accompanied by bacterial infection, combined with the emergence of bacterial infectious inflammation, I have previously had a special push, interested partners can refer to. After the diagnosis is confirmed, the treatment method is highly debated in the academic world, and there are no clear clinical norms and treatment guidelines so far, so it shows that this type of disease is complex and variable, with a variety of manifestations and a wide range of treatment results. The actual fact is that you can find a lot of people who have been in the business for a long time. The non-pregnancy lactation “inflammation” of the breast hides a great danger and is really a bad wolf in sheep’s clothing, patients in this situation should also be extremely vigilant, not to think they are, not to trust the “anti-inflammatory treatment”, must go to the breast specialist consultation. The actual diagnosis must be clear before receiving treatment, life and breasts are to be taken care of.